抑制IP6K1通过提高循环的阿波利波蛋白A-I,从而赋予动脉动脉保护
Xiaoqi Liu1, Zixuan Zhang1, Tim Aguirre2
1Tianjin Key Laboratory of Metabolic Diseases, Department of Physiology and Pathophysiology, The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, 22 Qixiangtai Road, Tianjin 300070, China.
Metabolism: clinical and experimental
|December 6, 2024
概括
阻断IP6K1通过防止其降解,增加了阿波利波蛋白A-I (apoA-I) 的产生. 这一策略提高了循环的apoA-I,减少了动脉样硬化,并为心血管疾病提供了潜在的治疗方法.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 心血管研究研究心血管研究
背景情况:
- 动脉样性心血管疾病是全球死亡的主要原因.
- 脂蛋白A-I (apoA-I) 在胆固醇排放中起着至关重要的作用,介导对动脉样硬化的保护.
- 规范AoA-I水平的监管机制仍然不完全理解.
研究的目的:
- 阐明控制阿波利波蛋白A-I (apoA-I) 生产的监管机制.
- 研究IP6K1在apoA-I降解中的作用及其作为治疗点的潜力.
主要方法:
- 同免疫沉试验用于研究蛋白质与蛋白质相互作用.
- 化学生物学工具,以确定5PP-InsP5.5的约束性合作伙伴和功能.
- 通过AAV-PCSK9和西方饮食诱导的动脉样的小鼠模型,通过Oil Red O和H&E染色进行斑块分析.
主要成果:
- 抑制IP6K1活动可以增强肝细胞中apoA-I的产生.
- IP6K1产品5PP-InsP5通过涉及UBE4A的无化调解apoA-I降解.
- 肝细胞特异性IP6K1删除增加了循环的apoA-I,增加了胆固醇流量,并减少了动脉样硬化负担.
- 通过IP6K1删除的动脉保护取决于apoA-I.
结论:
- 阻止IP6K1活动提供了一种新的机制来增加apoA-I的产生.
- 向IP6K1是一种有前途的治疗策略,可以提高apoA-I并实现动脉保护.
相关概念视频
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
cAMP-dependent Protein Kinase Pathways
6.1K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.1K
Feedback Inhibition
53.7K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.7K
Phosphoinositides and PIPs
8.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.4K
IP3/DAG Signaling Pathway
11.9K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.9K


